Anup Malani to Cost-Benefit Analysis
This is a "connection" page, showing publications Anup Malani has written about Cost-Benefit Analysis.
Connection Strength
0.061
-
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nat Med. 2022 05; 28(5):934-938.
Score: 0.037
-
The need for better evidence to evaluate the health & economic benefits of India's Rashtriya Swasthya Bima Yojana. Indian J Med Res. 2015 Oct; 142(4):383-90.
Score: 0.024